Latest News & Updates
Other trending news you may like to read
Commit Biologics Appoints Thomas L. F. Montgomery Andresen, Ph.D., As CEO As Company Prepares To Enter Clinical Development Following €21.5M Seed Backing From Novo Holdings
Commit Biologics Appoints Thomas L. F. Montgomery Andresen, Ph.D., As CEO As Company Prepares To Enter Clinical Development Following €21.5M Seed Backing From Novo Holdings
Simantini Singh Deo
Clearmind Medicine Begins Enrollment For Third Cohort In FDA-Approved Phase I/IIa Trial Of Non-Hallucinogenic AUD Treatment CMND-100
Clearmind Medicine Inc. begins third cohort enrollment for CMND-100 trial targeting Alcohol Use Disorder.
Simantini Singh Deo
Bavarian Nordic A/S Expands Partnership With Serum Institute Of India Pvt. Ltd. Through New Manufacturing Agreement For CHIKV VLP Chikungunya Vaccine
Bavarian Nordic A/S and Serum Institute of India Pvt. Ltd. expand partnership to scale manufacturing of the CHIKV VLP chikungunya vaccine.
Simantini Singh Deo
Quoin Pharmaceuticals Receives FDA Fast Track Designation For QRX003 Lotion To Advance Treatment For Netherton Syndrome
Quoin Pharmaceuticals Receives FDA Fast Track Designation For QRX003 Lotion To Advance Treatment For Netherton Syndrome
Simantini Singh Deo
